
Navidea Biopharma (NAVB)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Navidea Biopharma (NAVB) Stock
Start investing in Navidea Biopharma (NAVB)
About Navidea Biopharma (NAVB)
Market cap | $100.1K |
Yesterday's volume | 5.5K |
Revenue (TTM) | — |
Avg. daily volume | 4.04K |
EBITDA (TTM) | — |
Open | $0.00 |
Price / earnings ratio | — |
Yesterday's range | $0 - $0 |
Debt / equity | — |
52 week range | — |
5 year debt / equity | — |
Beta (LTM) | 5.49x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Nov 14, 2023 |
Dividend payable date | — |
Navidea Biopharma Stock Rating
Navidea Biopharma Stock News
View all



Frequently Asked Questions (FAQ)
How to buy NAVB stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 4
Manage your investments in one place
You can find your newly purchased NAVB stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Navidea Biopharma Stock Earnings
The value each NAVB share was expected to gain vs. the value that each NAVB share actually gained.
Navidea Biopharma (NAVB) reported Q3 2021 earnings per share (EPS) of -$0.08, beating estimates of -$0.11 by 27.27%. In the same quarter last year, Navidea Biopharma's earnings per share (EPS) was -$0.13. Navidea Biopharma is expected to release next earnings on 11/14/2023, with an earnings per share (EPS) estimate of $0.